<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02671240</url>
  </required_header>
  <id_info>
    <org_study_id>6246</org_study_id>
    <nct_id>NCT02671240</nct_id>
  </id_info>
  <brief_title>Prognosis of Behavioral Addiction in Parkinson's Disease</brief_title>
  <acronym>PROBA-PD</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our hypothesis is that the conventional treatment of Behavioral Addiction in Parkinson's
      disease is often not effective, and that affects the motor aspects (worsening akinéto-rigid
      syndrome and / or worsening of dyskinesia due to higher levodopa doses to compensate for the
      drop in behavioral addictions) and non-motor (withdrawal syndrome dopamine agonist) anxiously
      including apathy.

      Our goal is to describe the natural history of Behavioral Addiction under the effect of the
      evolution of the disease and adapt treatment according to the prior art, through a study of a
      larger population of patients than in the few published studies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2016</start_date>
  <completion_date type="Anticipated">October 24, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 24, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival time before disappearance of behavioral addiction defined by a score of less than 2 on the scale of behavioral assessment of Parkinson's disease</measure>
    <time_frame>12 months after selection</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Addiction</condition>
  <arm_group>
    <arm_group_label>- Patients with behavioral addiction</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>- Patients with no behavioral addiction</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Parkinson's disease who developed or not a behavioral addiction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age greater than or equal to 30 years

          -  Parkinson's disease according to the criteria of UKPDSBB

          -  Time evolution of the top disease or equal to 5 years

        Exclusion criteria:

          -  Lack of Parkinson's disease and atypical parkinsonism

          -  Patient not previously included in PD-BADGE
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu ANHEIM, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu ANHEIM, MD, PhD</last_name>
    <phone>33 (0)3 88 12 85 32</phone>
    <email>mathieu.anheim@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Neurologie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu ANHEIM, MD, PhD</last_name>
      <phone>03 88 12 85 32</phone>
      <email>mathieu.anheim@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2016</study_first_submitted>
  <study_first_submitted_qc>January 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson disease</keyword>
  <keyword>behavioral addiction</keyword>
  <keyword>akinéto-rigid syndrome</keyword>
  <keyword>dopamine agonist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

